Drug Profile
EP 70905
Latest Information Update: 07 Feb 2005
Price :
$50
*
At a glance
- Originator Ardana Bioscience
- Class
- Mechanism of Action Protein kinase C stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 07 Feb 2005 Discontinued - Preclinical for Cardiovascular disorders in Canada (unspecified route)
- 07 Feb 2005 Discontinued - Preclinical for Cardiovascular disorders in France (unspecified route)
- 06 Sep 2004 No development reported - Preclinical for Cardiovascular disorders in Canada (unspecified route)